Friday, August 21, 2026
21.8 C
Bengaluru

National Seminar on UCPMP

National Seminar on Uniform Code of Pharmaceutical Marketing Practices (UCPMP) - Karnataka Drug and Pharmaceutical Producers Association (KDPMA)

Theme: “Building Brands – Building a Future”

Friday, 16 September 2016 | Hotel Lalit Ashok, Kumara Krupa Road, Bangalore (Google Maps)


Seminar Objectives

The seminar will help companies especially Product Management Teams and Sales Teams to understand their changing roles due to UCPMP. It will also bring clarity on strategies and promotional inputs including CME’s, sampling, gifts etc. Part of deliberation will also cover monitoring and implementation of UCPMP. The eminent speakers will also share their perspective on the future of brand building in the post-UCPMP era.


Keynote Speaker

  • Shri. Sudhansh Pant, IAS – Joint Secretary, Dept. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India

Speakers

  • Dr. Ganesh Nayak – Executive Director and CEO, Zydus Cadila Ltd.
  • Anup Soans – Editor, MedicinMan
  • Samir Rai – National Sales Manager, Meyer Organics (Sales and Marketing, in charge of 4 divisions.)
  • Dr. H. N. Ravindra – Executive Committee Member, Indian Medical Council, New Delhi

Registration

Download the registration form below and mail to the address mentioned within.

[wpfilebase tag=file id=81 tpl=thumbnail target=blank/]

 

 

 

Hot this week

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Topics

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img